Table 3.
Proteins | Median TB (pg/mL) | 25%–75% TB (pg/mL) | Median non-TB (pg/mL) | 25%–75% non-TB (pg/mL) | P value | FDR | Ratio | Cohen's d |
MIG | 2490.5 | 1121.3–6512.4 | 609.2 | 295.9–1312.9 | 0 | 0 | 0.831 | 0.226 |
Furin | 0 | 0–5.697 | 245.18 | 10.11–352.18 | 0 | 0.001 | −2.065 | −0.195 |
I-309 | 5.792 | 3.058–10.982 | 1.9 | 1.087–3.23 | 0 | 0.001 | 1.389 | 0.847 |
IL-1 F7 | 1785.8 | 1506.6–2021.3 | 1321.1 | 1109.3–1657.4 | 0 | 0.002 | −0.574 | −0.105 |
EGFR | 3242 | 2786–3775 | 4246 | 3478–4935 | 0 | 0.002 | −0.317 | −0.789 |
I-TAC | 100.27 | 61.11–198.06 | 48.04 | 28.84–84.45 | 0 | 0.003 | 0.765 | 0.513 |
MEP1B | 372.76 | 28.38–756.09 | 894.8 | 413.3–1479.9 | 0 | 0.006 | −1.273 | −0.55 |
Granulysin | 514.38 | 296.66–837.17 | 945 | 555.1–1641.4 | 0 | 0.013 | −0.664 | −0.558 |
MDGA1 | 206 | 117.19–258.77 | 294.83 | 186.64–553.11 | 0 | 0.017 | −1.075 | −0.486 |
FAP | 5999 | 5613–7308 | 7213 | 6376–8744 | 0.001 | 0.025 | −0.246 | −0.645 |
FOLR2 | 1205.8 | 929.2–1943.5 | 880.07 | 469.61–1224.33 | 0.001 | 0.025 | 0.542 | 0.663 |
PDGF-CC | 69.78 | 0–316.87 | 0 | 0–70.69 | 0.001 | 0.025 | 0.696 | 0.189 |
IGFBP-5 | 0 | 0–0 | 51.04 | 0–785.55 | 0 | 0.025 | −4.24 | −0.177 |
LYVE-1 | 767.2 | 712.2–917.2 | 694.8 | 626.1–768.2 | 0.001 | 0.029 | 0.271 | 0.824 |
CRIM1 | 121.69 | 90.25–168.92 | 157.89 | 113.99–238.47 | 0.001 | 0.035 | −0.659 | −0.572 |
CHI3L1 | 2922 | 2527–3503 | 2293.6 | 1714.7–3171.7 | 0.001 | 0.035 | 0.265 | 0.4 |
Ratio: log2 (fold change); ratio >0, upregulation in TB; ratio <0, upregulation in non-TB.
CHI3L1, chitinase-3-like protein 1; CRIM1, cysteine rich transmembrane BMP regulator 1; EFGR, epidermal growth factor receptor; IL-1 F7, interleukin-1 family member 7 ; FAP, fibroblast activation protein; FDR, false discovery rate; FOLR2, folate receptor beta; I-309, also called CCL1/TCA3; IGFBP-5, insulin-like growth factor-binding protein 5; I-TAC, interferon-inducible T-cell alpha chemoattractant; LYVE1, lymphatic vessel endothelial hyaluronan receptor 1; MDGA1, MAM domain containing glycosylphosphatidylinositol anchor1; MEP1B, meprin A subunit beta; MIG, monokine induced by gamma interferon; PDGF-CC, platelet-derived growth factor-CC.